Alice BRUSCOLINI

Dr. Alice BRUSCOLINI

Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ABAlice BRUSCOLINI
Alice BRUSCOLINI
Marta SacchettiMarta Sacchetti
Marta Sacchetti
MCMaurizio La Cava
Maurizio La Cava
MGMagda Gharbiya
Magda Gharbiya
Massimo RalliMassimo Ralli
Massimo Ralli
Antonio GrecoAntonio Greco
Antonio Greco

1 July 2018 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ABAlice BRUSCOLINI
Alice BRUSCOLINI
Marta SacchettiMarta Sacchetti
Marta Sacchetti
MCMaurizio La Cava
Maurizio La Cava
Marcella NebbiosoMarcella Nebbioso
Marcella Nebbioso
AIAngela Iannitelli
Angela Iannitelli
Antonio GrecoAntonio Greco
Antonio Greco

11 October 2018 in Stem Cells International
Verified
Journal Article
Open access
PDF file
Marta SacchettiMarta Sacchetti
Marta Sacchetti
PRPaolo Rama
Paolo Rama
ABAlice BRUSCOLINI
Alice BRUSCOLINI
ALAlessandro Lambiase
Alessandro Lambiase
Limbal stem cell deficiency (LSCD) is a clinical condition characterized by damage of cornea limbal stem cells, which results in an impairment of corneal epithelium turnover and in an invasion of the cornea by the conjunctival epithelium. In these patients, the conjunctivalization of the cornea is associated with visual impairment and cornea transplantation has poor prognosis for recurrence of the conjunctivalization. Current treatments of LSCD are aimed at replacing the damaged corneal stem cells in order to restore a healthy corneal epithelium. The autotransplantation of limbal tissue from the healthy, fellow eye is effective in unilateral LSCD but leads to depauperation of the stem cell reservoir. In the last decades, novel techniques such as cultivated limbal epithelial transplantation (CLET) have been proposed in order to reduce the damage of the healthy fellow eye. Clinical and experimental evidence showed that CLET is effective in inducing long-term regeneration of a healthy corneal epithelium in patients with LSCD with a success rate of 70%–80%. Current limitations for the treatment of LSCD are represented by the lack of a marker able to unequivocally identify limbal stem cells and the treatment of total, bilateral LSCD which requires other sources of stem cells for ocular surface reconstruction.

16 September 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FMFlavio Mantelli
Flavio Mantelli
CNChiara Nardella
Chiara Nardella
ETEloisa Tiberi
Eloisa Tiberi
Marta SacchettiMarta Sacchetti
Marta Sacchetti
ABAlice BRUSCOLINI
Alice BRUSCOLINI
ALAlessandro Lambiase
Alessandro Lambiase
Neurotrophic keratitis (NK) is a rare degenerative disease of the cornea caused by an impairment of corneal sensory innervation, characterized by decreased or absent corneal sensitivity resulting in epithelial keratopathy, ulceration, and perforation. The aetiopathogenesis of corneal sensory innervation impairment in children recognizes the same range of causes as adults, although they are much less frequent in the pediatric population. Some extremely rare congenital diseases could be considered in the aetiopathogenesis of NK in children. Congenital corneal anesthesia is an extremely rare condition that carries considerable diagnostic and therapeutic problems. Typically the onset is up to 3 years of age and the cornea may be affected in isolation or the sensory deficit may exist as a component of a congenital syndrome, or it may be associated with systemic somatic anomalies. Accurate diagnosis and recognition of risk factors is important for lessening long-term sequelae of this condition. Treatment should include frequent topical lubrication and bandage corneal or scleral contact lenses. Surgery may be needed in refractory cases. The purpose of this review is to summarize and update data available on congenital causes and treatment of corneal hypo/anesthesia and, in turn, on congenital NK.

1 May 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
ALAlessandro Lambiase
Alessandro Lambiase
FMFlavio Mantelli
Flavio Mantelli
ABAlice BRUSCOLINI
Alice BRUSCOLINI
MCMaurizio La Cava
Maurizio La Cava
SASolmaz Abdolrahimzadeh
Solmaz Abdolrahimzadeh
Ocular manifestations of Sturgeâ??Weber syndrome: pathogenesis, diagnosis, and management Flavio Mantelli,1 Alice Bruscolini,2 Maurizio La Cava,2 Solmaz Abdolrahimzadeh,2 Alessandro Lambiase2 1Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA; 2Department of Sense Organs, Section of Ophthalmology, University of Rome â??Sapienzaâ??, Rome, Italy Sturgeâ??Weber syndrome has been included in the group of phakomatoses that is characterized by hamartomas involving the brain, skin, and eyes. The characteristic facial port-wine stain, involving the first branch of the trigeminal nerve and the embryonic vasculature distribution in this area, leads to several ocular complications of the anterior segment and can involve the eyelids and conjunctiva. The posterior segment of the eyes is also affected with diffuse choroidal hemangiomas. However, the most frequent ocular comorbidity is glaucoma with a prevalence rate ranging from 30%â??70%. Glaucoma is related to anterior chamber malformations, high episcleral venous pressure (EVP), and changes in ocular hemodynamics. Glaucoma can be diagnosed at birth, but the disease can also develop during childhood and in adults. The management of glaucoma in Sturgeâ??Weber syndrome patients is particularly challenging because of early onset, frequently associated severe visual field impairment at the time of diagnosis, and unresponsiveness to standard treatment. Several surgical approaches have been proposed, but long-term prognosis for both intraocular pressure control and visual function remains unsatisfactory in these patients. Choroidal hemangiomas may also lead to visual impairment thorough exudative retinal detachment and macular edema. Treatment of exudative hemangioma complications is aimed at destructing the tumor or decreasing tumor leakage. Keywords: Sturgeâ??Weber syndrome, glaucoma, choroidal hemangiomas, port-wine stain, congenital disease, glaucoma surgery

1 August 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
ATAlessandro Trebbastoni
Alessandro Trebbastoni
FDFabrizia D’aNtonio
Fabrizia D’aNtonio
ABAlice BRUSCOLINI
Alice BRUSCOLINI
MMMichela Marcelli
Michela Marcelli
MCMichela Cecere
Michela Cecere
MGMagda Gharbiya
Magda Gharbiya